COVID-19 thyroid disorders: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary Tag: Reverted |
Jose Loyola (talk | contribs) No edit summary Tag: Reverted |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Many covid-19 patients eventually develop thyroid disorders. 90% of them develop hyperthyroidism, while the rest of them develop hypothyroidism. | Many covid-19 patients eventually develop thyroid disorders. 90% of them develop hyperthyroidism, while the rest of them develop hypothyroidism.<ref name="pmid32438340">{{cite journal| author=Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L| title=ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism. | journal=Eur J Endocrinol | year= 2020 | volume= 183 | issue= 1 | pages= G33-G39 | pmid=32438340 | doi=10.1530/EJE-20-0445 | pmc=7938012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32438340 }} </ref> | ||
==Historical Perspective== | ==Historical Perspective== |
Revision as of 20:10, 23 May 2022
Template:COVID-19 thyroid disorders
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Many covid-19 patients eventually develop thyroid disorders. 90% of them develop hyperthyroidism, while the rest of them develop hypothyroidism.[1]
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating ((Page name)) from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
References
- ↑ Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L (2020). "ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism". Eur J Endocrinol. 183 (1): G33–G39. doi:10.1530/EJE-20-0445. PMC 7938012 Check
|pmc=
value (help). PMID 32438340 Check|pmid=
value (help).